The relationship of early- and late-onset Alzheimer's disease genes with COVID-19.
Ontology highlight
ABSTRACT: Individuals with Alzheimer's disease and other neurodegenerative diseases have been exposed to excess risk by the COVID-19 pandemic. COVID-19's main manifestations include high body temperature, dry cough, and exhaustion. Nevertheless, some affected individuals may have an atypical presentation at diagnosis but suffer neurological signs and symptoms as the first disease manifestation. These findings collectively show the neurotropic nature of SARS-CoV-2 virus and its ability to involve the central nervous system. In addition, Alzheimer's disease and COVID-19 has a number of common risk factors and comorbid conditions including age, sex, hypertension, diabetes, and the expression of APOE ε4. Until now, a plethora of studies have examined the COVID-19 disease but only a few studies has yet e
SUBMITTER: Sirin S
PROVIDER: S-EPMC9012910 | biostudies-literature | 2022 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA